PTGS2 and neoplasm: Silymarin has been shown to inhibit skin carcinogenesis [4]–[6], and has pleiotropic activities which include the inhibition of cyclooxygenase-2 (COX-2) activity and an inhibitor of polyamine biosynthesis [4], [5].